Matches in Harvard for { <http://id.lib.harvard.edu/aleph/000722780/catalog> ?p ?o. }
Showing items 1 to 48 of
48
with 100 items per page.
- catalog abstract "In the United States, drug companies promoting their products to physicians are required by law to limit their claims to what they can prove, and to make full disclosure of all known hazards. Dr. Silverman, a noted science writer and pharmacologist, finds that many multinational drug companies are circumventing similar laws in Latin America in order to sell more of their products. The author provides detailed comparisons of the promotion of 28 separate prescription drugs in the U.S. and in Mexico, Central America, and other Latin American countries. Typically, claims for effectiveness are exaggerated in Latin America and the hazards are glossed over. This practice, denounced by Latin American medical experts and appalling even to scientists within the drug industry, is blamed for needless patient injury and death. When called upon to explain the inconsistencies in their promotional campaigns, their standard defense is "we're not breaking any laws." But some of these global companies have been breaking laws. They have been lying. In the United States, the major pharmaceutical companies have long and vociferously assailed the laws which now require them to restrict claims of efficacy of their products to those they can support with substantial scientific evidence and to inform physicians fully of all hazards. The companies argue that these rules are excessively harsh and that these laws and regulations are not necessary because the industry recognizes its social responsibilities and would live up to them, laws or no laws. The information presented here is a partial response to such an argument. It demonstrates that a problem exists and shows how some companies comport themselves when there are no restrictive laws, or when the laws are not enforced. -- from Preface.".
- catalog contributor b935041.
- catalog coverage "Latin America".
- catalog coverage "United States".
- catalog coverage "United States.".
- catalog created "c1976.".
- catalog date "1976".
- catalog date "c1976.".
- catalog dateCopyrighted "c1976.".
- catalog description "In the United States, drug companies promoting their products to physicians are required by law to limit their claims to what they can prove, and to make full disclosure of all known hazards. Dr. Silverman, a noted science writer and pharmacologist, finds that many multinational drug companies are circumventing similar laws in Latin America in order to sell more of their products. The author provides detailed comparisons of the promotion of 28 separate prescription drugs in the U.S. and in Mexico, Central America, and other Latin American countries. Typically, claims for effectiveness are exaggerated in Latin America and the hazards are glossed over. This practice, denounced by Latin American medical experts and appalling even to scientists within the drug industry, is blamed for needless patient injury and death. When called upon to explain the inconsistencies in their promotional campaigns, their standard defense is "we're not breaking any laws." But some of these global companies have been breaking laws. They have been lying. In the United States, the major pharmaceutical companies have long and vociferously assailed the laws which now require them to restrict claims of efficacy of their products to those they can support with substantial scientific evidence and to inform physicians fully of all hazards. The companies argue that these rules are excessively harsh and that these laws and regulations are not necessary because the industry recognizes its social responsibilities and would live up to them, laws or no laws. The information presented here is a partial response to such an argument. It demonstrates that a problem exists and shows how some companies comport themselves when there are no restrictive laws, or when the laws are not enforced. -- from Preface.".
- catalog description "Includes bibliographical references and index.".
- catalog description "Introduction -- Antibiotics -- Oral contraceptives -- Nonsteroid antiarthritics -- Steroid hormones -- Antipsychotic tranquilizers -- Antidepressants -- Anticonvulsants -- Discussion: the epidemiology of drug promotion.".
- catalog extent "xiv, 147 p. ;".
- catalog issued "1976".
- catalog issued "c1976.".
- catalog language "eng".
- catalog publisher "Berkeley : University of California Press,".
- catalog spatial "Developing countries.".
- catalog spatial "Latin America".
- catalog spatial "Latin America.".
- catalog spatial "United States".
- catalog spatial "United States.".
- catalog subject "614.3/5/098".
- catalog subject "Advertising Drugs.".
- catalog subject "Advertising as Topic Latin America.".
- catalog subject "Advertising as Topic United States.".
- catalog subject "Advertising as Topic".
- catalog subject "Advertising laws.".
- catalog subject "Ambiguity in advertising.".
- catalog subject "Deceptive advertising Latin America.".
- catalog subject "Deceptive advertising.".
- catalog subject "Drug Industry Latin America.".
- catalog subject "Drug Industry United States.".
- catalog subject "Drug Industry".
- catalog subject "Drug Therapy adverse effects".
- catalog subject "Drug-Related Side Effects and Adverse Reactions Latin America.".
- catalog subject "Drug-Related Side Effects and Adverse Reactions United States.".
- catalog subject "Drugs Marketing.".
- catalog subject "Drugs Side effects.".
- catalog subject "Pharmaceutical industry Corrupt practices Developing countries.".
- catalog subject "Pharmaceutical industry Corrupt practices.".
- catalog subject "Pharmaceutical industry Ethics.".
- catalog subject "Pharmaceutical industry Latin America.".
- catalog subject "QV 736 S587d 1976".
- catalog subject "RM301 .S53".
- catalog tableOfContents "Introduction -- Antibiotics -- Oral contraceptives -- Nonsteroid antiarthritics -- Steroid hormones -- Antipsychotic tranquilizers -- Antidepressants -- Anticonvulsants -- Discussion: the epidemiology of drug promotion.".
- catalog title "The drugging of the Americas : how multinational drug companies say one thing about their products to physicians in the United States, and another thing to physicians in Latin America / by Milton Silverman.".
- catalog type "text".